Due to our fast forward innovative approach to the pandemic, we are delighted to announce three additional products to our portfolio.
COVID-19 has proven to be complex, and multifaceted, that’s why we are constantly innovating and evolving. We know that a single solution cannot solve all the issues that our healthcare professionals are facing, but we are proud to be able to help support them where we can, by delivering products that can diagnose and produce crucial data on this virus.
➔ An alternative to next generation sequencing
and S gene target failure (SGTF), it enables
scientists to analyse and monitor these
specific genomic mutations.
➔ Pivotal in the role of screening for SARS-CoV-
2 Variants for the purpose
SNPsig® SARS-CoV-2 VOC Identification Kits
